Literature DB >> 1141727

Neutrophil dysfunction in diabetes mellitus.

J S Tan, J L Anderson, C Watanakunakorn, J P Phair.   

Abstract

The neutrophil bactericidal capacity of 31 patients with diabetes mellitus in a nonketoacidotic state, including 21 without infections and 10 with recurrent infections, were evaluated. The killed intracellular bacteria (KICB) expressed as the percentage of the initial inoculum for 25 normal control subjects was 95.4 (SD equal plus and minus (2.7) and that for the diabetic patients, the KICB was 72.8 (SD=+30.7)with a p value of less than or equal to 0.01. In 17 out of 31 diabetic atients, the KICB was greater than minus two standard deviations of the control mean. Using the lysostaphin assay technic, 11 patients were shown to phagocytize poorly, 3 had impaired intracellular killing and 3 had a combined defect. These defects were not correctable by normal serum nor related to blood-glucose levels. No apparent correlation with infection could be demonstrated. Fiver of the 10 patients with recurrent infections and 12 out ot of 21 patients without infections has a neutrophil dysfunction. However, all 3 patients with a combined defect had severe bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141727

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  33 in total

1.  Elevated glucose concentrations promote receptor-independent activation of adherent human neutrophils: an experimental and computational approach.

Authors:  Ursula Kummer; Jürgen Zobeley; Jens Christian Brasen; Ryan Fahmy; Andrei L Kindzelskii; Aaron R Petty; Andrea J Clark; Howard R Petty
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

2.  Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Authors:  Ahmet Ozer; Cengiz Z Altuntas; Fuat Bicer; Kenan Izgi; Scott J Hultgren; Guiming Liu; Firouz Daneshgari
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

3.  Changes in phagocytic function with glycaemic control in diabetic patients.

Authors:  S M MacRury; C G Gemmell; K R Paterson; A C MacCuish
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

4.  Immunity in diabetes mellitus: impaired or enhanced?

Authors:  H R Hill
Journal:  West J Med       Date:  1979-06

5.  Risk factors for tissue and wound complications in gastrointestinal surgery.

Authors:  Lars Tue Sørensen; Ulla Hemmingsen; Finn Kallehave; Peer Wille-Jørgensen; Johan Kjaergaard; Lisbeth Nørgaard Møller; Torben Jørgensen
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

6.  Suppressed collagenolytic activity in polymorphonuclear leucocytes from diabetic humans.

Authors:  G A Nicoll; G M Gollapudi; N S Ramamurthy; L M Golub
Journal:  Experientia       Date:  1981-03-15

7.  [Acquired functional defects of granulocytes and monocytes in adult patients with diabetes mellitus (author's transl)].

Authors:  A F Viollier; H J Senn
Journal:  Blut       Date:  1982-01

Review 8.  Inpatient diabetology. The new frontier.

Authors:  Nicolas N Abourizk; Chaula K Vora; Parveen K Verma
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

9.  The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing.

Authors:  S E Tebbs; A M Gonzalez; R M Wilson
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

10.  Pylephlebitis and pyogenic liver abscesses: a complication of hemorrhoidal banding.

Authors:  Nicole G Chau; Sacha Bhatia; Maitreyi Raman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.